Go to Top
[maxbutton id="1"]


STC Deal Featured in National Technology Transfer Publication

Albuquerque, NM – November 10, 2014 Technology Transfer Tactics, a national monthly publication providing strategies, case studies, and best practices on a broad range of topics for technology transfer offices and professionals, has published an article in its September issue on STC’s licensing deal with Sunbelt Technologies for a large portfolio of pharmaceuticals developed at the University of New Mexico’s Center for Molecular Discovery. To read “Universities Use Third Parties …Read More

Sandia Biotech and STC.UNM Announce Option Agreement to License Novel UNM Antibody Technology

Albuquerque, NM – September 15, 2014 Sandia Biotech, Inc. announced today that the company has signed an exclusive option agreement with STC.UNM (STC) for a technology developed by researchers at the University of New Mexico (UNM) in Albuquerque, New Mexico, and Queen Mary University of London in London, England. The group of technologies, called the Recombinant Fluorescent Antibody Technology Platform (RFAP) and developed by Dr. Ravi Durvasula from UNM’s Department …Read More